Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13143012 | 0.73 | TSHR (0.35) | TSHRACHEALDH1A1PTPN1 | |
| SCHEMBL9534820 | 0.73 | PTPN1 (0.34) | ACHEALDH1A1POLBPTPN1 | |
| SCHEMBL5281483 | 0.73 | TSHR (0.43) | TSHRACHEALDH1A1PTPN1 | |
| SCHEMBL7235362 | 0.71 | ALDH1A1 (0.33) | TSHRACHEALDH1A1PTPN1 | |
| SCHEMBL17620913 | 0.70 | TSHR (0.36) | TSHR | |
| SCHEMBL125009 | 0.70 | ACHE (0.32) | TSHRACHEALDH1A1 | |
| SCHEMBL125436 | 0.70 | POLB (0.39) | TSHRACHEALDH1A1POLB | |
| SCHEMBL7237915 | 0.70 | PTPN1 (0.35) | TSHRACHEPOLBPTPN1 | |
| SCHEMBL7682479 | 0.69 | ACHE (0.32) | TSHRACHEALDH1A1 | |
| SCHEMBL12844899 | 0.69 | ACHE (0.32) | TSHRACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577270-B2 | 2′,3′-diacetyluridine substituted with acetoacetyl at the 5′ position | PHARMA CINQ, LLC (US) | 2026-03-17 | — | — | US | claimed |
| CN-118026974-A | Chromonol containing difuran diamine structure and disazo pigment derived from same | 江苏丽王科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-20230357304-A1 | 2′,3′-Diacetyluridine Substituted With Acetoacetyl at the 5′ Position | WELLSTAT THERAPEUTICS CORPORATION | 2023-11-09 | — | — | US | claimed |
| EP-4210709-A1 | 2',3'-DIACETYLURIDINE SUBSTITUTED WITH ACETOACETYL AT THE 5' POSITION | Wellstat Therapeutics Corporation (US) | 2023-07-19 | — | — | EP | claimed |
| US-20230102379-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | POINT LOMA NAZARENE UNIVERSITY | 2023-03-30 | — | — | US | claimed |
| WO-2023002984-A1 | METHOD FOR PRODUCING IMIDAZOLE COMPOUND | 小野薬品工業株式会社 | 2023-01-26 | — | — | WO | claimed |
| WO-2022077852-A1 | 3,5-DICARBOXYLIC ACID ESTER-1,4-DIHYDROPYRIDINE HYDROGENATING REAGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 中山奕安泰医药科技有限公司 | 2022-04-21 | — | — | WO | claimed |
| CN-114349687-A | 3, 5-dicarboxylic ester-1, 4-dihydropyridine hydrogenation reagent and preparation method and application thereof | 中山奕安泰医药科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114349685-A | 3, 5-diamide-1, 4-dihydropyridine hydrogenation reagent and preparation method and application thereof | 中山奕安泰医药科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| WO-2021150951-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | claimed |
| US-5326378-A | Tris (2-acetoacetoxy ethyl)-amine, and its hydrosoluble salts, preparation process, use as formaldehyde collectors and finishing process for fabrics | SOCIETE FRANCAISE HOECHST (FR) | 1994-07-05 | — | — | US | claimed |
| WO-1994013725-A1 | PROCESS FOR THE PRODUCTION OF POLYURETHANE FOAMS | EASTMAN CHEMICAL COMPANY (US) | 1994-06-23 | — | — | WO | claimed |
| EP-0598038-A1 | CELLULOSE ACETOACETATES. | EASTMAN KODAK CO (US) | 1994-05-25 | — | — | EP | claimed |
| US-5292877-A | Cellulose acetoacetates | EASTMAN KODAK COMPANY (US) | 1994-03-08 | — | — | US | claimed |
| US-5234965-A | Acetoacetylation of some hydroxy groups of a polyhydric compound used to react with polyisocyanate in the presence of a blowing agent and catalyst to lower the viscosity | EASTMAN KODAK COMPANY (US) | 1993-08-10 | — | — | US | claimed |
| WO-1993003063-A1 | CELLULOSE ACETOACETATES | EASTMAN CHEMICAL COMPANY (US) | 1993-02-18 | — | — | WO | claimed |
| US-4992584-A | Using homogeneous solution of 1,3-dioxin-4-one and a,b-unsaturated amide | EASTMAN KODAK COMPANY (US) | 1991-02-12 | — | — | US | claimed |
| US-4551523-A | Preparation of saccharide acetoacetates | EASTMAN KODAK COMPANY (US) | 1985-11-05 | — | — | US | claimed |
| US-4496747-A | Process for the preparation of dehydroacetic acid | EASTMAN KODAK COMPANY (US) | 1985-01-29 | — | — | US | claimed |
| US-3931171-A | FROM A 1,3-DIOXINONE-(4) AND AN ISOCYANATE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230102379-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | LSS, REL, RPN1 | TSHR 4599/4885ACHE 75/4885ALDH1A1 1897/4885 |
| US-12577270-B2 | 2′,3′-diacetyluridine substituted with acetoacetyl at the 5′ position | UQCRC2, ACAT1, ACAA2 | TSHR 3434/4885ACHE 2299/4885ALDH1A1 185/4885 |
| US-20230357304-A1 | 2′,3′-Diacetyluridine Substituted With Acetoacetyl at the 5′ Position | ACAT1, ACADVL, ACAA2 | TSHR 3094/4885ACHE 3169/4885ALDH1A1 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.